ALTO NEUROSCIENCE INC
ANRO·02157Q109·US·Common Stock·Healthcare - Biotechnology-13D/G
ANRO (ALTO NEUROSCIENCE INC) is held by 68 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($27.1M), FRANKLIN RESOURCES INC ($24.8M), MILLENNIUM MANAGEMENT LLC ($18.5M). Net institutional sentiment: Mixed.
68
Holders
(4 Elite)
$208.7M
Total Value
51% (67)
Consensus
34 buying - 33 selling
13F: Insider & Congress:
Who's Trading
ActivistCOCommodore Capital LP9.9%May 15, 2026
ActivistSISirenia Capital Management LP7.9%May 15, 2026
ActivistVPVestal Point Capital, LP6.5%May 15, 2026
ActivistARArmistice Capital, LLC4.9%Feb 18, 2026
ActivistPAPerceptive Advisors LLC10.0%Feb 17, 2026
ActivistARArmistice Capital, LLC6.0%Feb 17, 2026
ActivistKHK2 HealthVentures Equity Trust LLC2.4%Feb 17, 2026
Showing 1-20 of 70
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer